Pinnacle Financial Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-130
| Closed | -$35.2K | – | 525 |
|
|
2024
Q2 | $35.2K | Hold |
130
| – | – | ﹤0.01% | 493 |
|
|
2024
Q1 | $35.2K | Hold |
130
| – | – | ﹤0.01% | 488 |
|
|
2023
Q4 | $30.7K | Hold |
130
| – | – | ﹤0.01% | 474 |
|
|
2023
Q3 | $25.5K | Hold |
130
| – | – | ﹤0.01% | 459 |
|
|
2023
Q2 | $27.3K | Hold |
130
| – | – | ﹤0.01% | 465 |
|
|
2023
Q1 | $26.2K | Hold |
130
| – | – | ﹤0.01% | 460 |
|
|
2022
Q4 | $28.3K | Hold |
130
| – | – | ﹤0.01% | 446 |
|
|
2022
Q3 | $26K | Buy |
+130
| New | +$26K | ﹤0.01% | 441 |
|
|
2022
Q2 | – | Sell |
-134
| Closed | -$38K | – | 435 |
|
|
2022
Q1 | $38K | Hold |
134
| – | – | ﹤0.01% | 397 |
|
|
2021
Q4 | $50K | Hold |
134
| – | – | ﹤0.01% | 417 |
|
|
2021
Q3 | $55K | Hold |
134
| – | – | ﹤0.01% | 399 |
|
|
2021
Q2 | $50K | Buy |
+134
| New | +$50K | ﹤0.01% | 393 |
|